{"id":"https://openalex.org/W2880120006","doi":"https://doi.org/10.5465/ambpp.2018.12352abstract","title":"Pushing for speed or scope? Pharmaceutical lobbying and FDA drug review (WITHDRAWN)","display_name":"Pushing for speed or scope? Pharmaceutical lobbying and FDA drug review (WITHDRAWN)","publication_year":2018,"publication_date":"2018-07-09","ids":{"openalex":"https://openalex.org/W2880120006","doi":"https://doi.org/10.5465/ambpp.2018.12352abstract","mag":"2880120006"},"language":"en","primary_location":{"id":"doi:10.5465/ambpp.2018.12352abstract","doi":"https://doi.org/10.5465/ambpp.2018.12352abstract","is_oa":false,"landing_page_url":"https://doi.org/10.5465/ambpp.2018.12352abstract","pdf_url":null,"source":{"id":"https://openalex.org/S4210223487","display_name":"Academy of Management Proceedings","issn_l":"0065-0668","issn":["0065-0668","2151-6561","2376-7197"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310316266","host_organization_name":"Academy of Management","host_organization_lineage":["https://openalex.org/P4310316266"],"host_organization_lineage_names":["Academy of Management"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Academy of Management Proceedings","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008073358","display_name":"Benjamin Barber","orcid":"https://orcid.org/0000-0001-6388-1464","observed_orcids":["https://orcid.org/0000-0001-6388-1464"]},"institutions":[{"id":"https://openalex.org/I125068653","display_name":"IE University","ror":"https://ror.org/02jjdwm75","country_code":"ES","type":"education","lineage":["https://openalex.org/I125068653"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Benjamin Barber Iv","raw_affiliation_strings":["IE Business SchoolIE Business School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IE Business SchoolIE Business School","institution_ids":["https://openalex.org/I125068653"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009499280","display_name":"Luis Diestre","orcid":"https://orcid.org/0000-0002-1815-509X","observed_orcids":["https://orcid.org/0000-0002-1815-509X"]},"institutions":[{"id":"https://openalex.org/I125068653","display_name":"IE University","ror":"https://ror.org/02jjdwm75","country_code":"ES","type":"education","lineage":["https://openalex.org/I125068653"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis Diestre","raw_affiliation_strings":["IE Business SchoolIE Business School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IE Business SchoolIE Business School","institution_ids":["https://openalex.org/I125068653"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I125068653"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"2018","issue":"1","first_page":"12352","last_page":"12352"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.41429999470710754,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.41429999470710754,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12225","display_name":"Political Influence and Corporate Strategies","score":0.31470000743865967,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.263700008392334,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-lobbying","display_name":"pharmaceutical lobbying","score":0.949999988079071},{"id":"https://openalex.org/keywords/fda-drug-review","display_name":"FDA drug review","score":0.8960000276565552},{"id":"https://openalex.org/keywords/drug-development-strategy","display_name":"drug development strategy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/intellectual-property-protection","display_name":"intellectual property protection","score":0.9819999933242798},{"id":"https://openalex.org/keywords/new-drug-application","display_name":"new drug applications","score":0.9330000281333923}],"concepts":[{"id":"https://openalex.org/C2778012447","wikidata":"https://www.wikidata.org/wiki/Q1034415","display_name":"Scope (computer science)","level":2,"score":0.8441944122314453},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6341841220855713},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.6182680726051331},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.5819076299667358},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5800777077674866},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.566885769367218},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.38385307788848877},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.33748921751976013},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2829933762550354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20871692895889282},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.13910126686096191},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5465/ambpp.2018.12352abstract","doi":"https://doi.org/10.5465/ambpp.2018.12352abstract","is_oa":false,"landing_page_url":"https://doi.org/10.5465/ambpp.2018.12352abstract","pdf_url":null,"source":{"id":"https://openalex.org/S4210223487","display_name":"Academy of Management Proceedings","issn_l":"0065-0668","issn":["0065-0668","2151-6561","2376-7197"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310316266","host_organization_name":"Academy of Management","host_organization_lineage":["https://openalex.org/P4310316266"],"host_organization_lineage_names":["Academy of Management"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Academy of Management Proceedings","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2921326515","https://openalex.org/W4385225474","https://openalex.org/W4390095083","https://openalex.org/W2890938542","https://openalex.org/W3121649172","https://openalex.org/W6941362954","https://openalex.org/W3021873128","https://openalex.org/W7132613915","https://openalex.org/W2622022047","https://openalex.org/W2036983269"],"abstract_inverted_index":{"Do":[0],"pharmaceutical":[1,30],"firms":[2,58,75,92,107],"lobby":[3,77,109],"the":[4,26,53,124],"FDA":[5,125],"to":[6,16,33,81,84,110,123,128],"get":[7],"their":[8,63,79,97],"drugs":[9,80],"approved":[10,83],"as":[11,13,18,21,86,89],"fast":[12],"possible":[14],"or":[15,40],"treat":[17,85],"many":[19,87],"diseases":[20,88],"possible?":[22],"We":[23,114],"argue":[24],"that":[25],"non-market":[27],"outcome":[28],"a":[29],"firm":[31],"tries":[32],"achieve":[34],"through":[35],"its":[36,45],"lobbying":[37],"efforts":[38],"(speed":[39],"scope)":[41],"is":[42,50,67],"contingent":[43],"on":[44,101,118],"drug":[46,64,71,103,121],"development":[47,65],"strategy,":[48],"which":[49],"determined":[51],"by":[52],"drug\u2019s":[54],"IP":[55,61,95],"protection.":[56],"When":[57,91],"have":[59,93],"strong":[60],"protection":[62,96],"strategy":[66,98],"aimed":[68],"at":[69],"maximizing":[70],"functionality,":[72],"so":[73,105],"these":[74,106],"will":[76,99,108],"for":[78,134],"be":[82],"possible.":[90],"weak":[94],"focus":[100],"accelerating":[102],"development,":[104],"shorten":[111],"revision":[112],"time.":[113],"test":[115],"our":[116,135],"hypotheses":[117],"540":[119],"new":[120],"applications":[122],"from":[126],"1998":[127],"2015":[129],"and":[130],"find":[131],"empirical":[132],"support":[133],"theory.":[136]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2018-07-19T00:00:00"}